GRDNGRDNNYSE

Overview Intelligence Charts News Fundamentals Key Metrics Earnings Growth Financials Insiders

Latest News

businesswire.com

Guardian Pharmacy Services Announces Pricing of Upsized Underwritten Public Offering of Class A Common Stock

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN) today announced the pricing of its upsized underwritten public offering (the “Offering”) of 6,000,000 shares of its Class A common stock at a public offering price of $31.00 per share, of which 4,980,000 shares will be sold by certain selling stockholders and 1,020,000 shares will be issued and sold by Guardian as part of a non-dilutive “synthetic secondary” transaction, as described below. In addition, the sel.

businesswire.com

Guardian Pharmacy Services Announces Launch of Underwritten Public Offering of Class A Common Stock

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN) today announced the launch of a proposed underwritten public offering (the “Offering”) of 5,000,000 shares of its Class A common stock, consisting of 3,980,000 shares being offered by certain selling stockholders and 1,020,000 newly issued shares being offered by Guardian as part of a non-dilutive “synthetic secondary” transaction, as described below. In addition, the selling stockholders intend to grant the un.

seekingalpha.com

Guardian Pharmacy Services, Inc. (GRDN) Q4 2025 Earnings Call Transcript

zacks.com

Guardian Pharmacy Services (GRDN) Surpasses Q4 Earnings and Revenue Estimates

Guardian Pharmacy Services (GRDN) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.24 per share a year ago.

businesswire.com

Guardian Pharmacy Services Reports Fourth Quarter and Full Year 2025 Financial Results; Raises 2026 Adjusted EBITDA Guidance

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the fourth quarter and full year ended December 31, 2025. The Company also raised its full-year 2026 Adjusted EBITDA guidance. Fourth Quarter Financial Results Revenue of $397.6 million, up 17% year-over-year with organic growth of 12%. Residents served ended the quarter at approximately 205,000, up 10%.

businesswire.com

Guardian Pharmacy Services, Inc. to Participate in Upcoming Oppenheimer Healthcare MedTech & Services Conference

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that the company will participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference. Fred Burke, President and Chief Executive Officer, and David Morris, Chief Financial Officer, will participate in a fireside chat on Monday, March 16, 2026, at 10:40 a.m. Eastern Time. A live audio webcast of the session will be available at https://investors.guardianpharmacy.com. A replay will be a.

zacks.com

All You Need to Know About Guardian Pharmacy (GRDN) Rating Upgrade to Buy

Guardian Pharmacy (GRDN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

businesswire.com

Guardian Pharmacy Services, Inc. to Participate in Upcoming Raymond James Institutional Investor Conference

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that the company will present at the Raymond James Institutional Investors Conference in Orlando, Florida on Monday, March 2 at 1:40 p.m. Eastern Time. A live audio webcast of the session will be available at https://investors.guardianpharmacy.com. A replay of the webcast will be accessible shortly after the event and will remain available for 90 days. About Guardian Pharmacy Services Guardian Pharmacy Servi.

businesswire.com

Guardian Pharmacy Services, Inc., to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will release fourth quarter and full-year 2025 financial results after market close on Wednesday, March 11, 2026. Management will host a conference call to discuss the results at 4:30 p.m. Eastern Time. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing +1 (646) 564-2877 for U.S. participants, o.

defenseworld.net

Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Average Rating of “Moderate Buy” by Brokerages

Guardian Pharmacy Services, Inc. (NYSE: GRDN - Get Free Report) has been given a consensus rating of "Moderate Buy" by the five brokerages that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year

defenseworld.net

Short Interest in Guardian Pharmacy Services, Inc. (NYSE:GRDN) Rises By 33.3%

Guardian Pharmacy Services, Inc. (NYSE: GRDN - Get Free Report) was the recipient of a significant increase in short interest during the month of January. As of January 15th, there was short interest totaling 1,543,962 shares, an increase of 33.3% from the December 31st total of 1,158,683 shares. Based on an average daily volume of 280,436

defenseworld.net

Rakuten Investment Management Inc. Takes Position in Guardian Pharmacy Services, Inc. $GRDN

Rakuten Investment Management Inc. purchased a new position in Guardian Pharmacy Services, Inc. (NYSE: GRDN) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 16,493 shares of the company's stock, valued at approximately $433,000. A number of other hedge funds also recently

seekingalpha.com

Guardian Pharmacy Services, Inc. (GRDN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

businesswire.com

Guardian Pharmacy Services Reiterates 2025 Guidance and Provides 2026 Outlook

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services (NYSE: GRDN), one of the nation's leading long-term care (“LTC”) pharmacy services companies, is reiterating its previously announced 2025 guidance and providing its preliminary financial outlook for 2026. The Company expects to continue its low double-digit adjusted EBITDA growth trajectory in 2026, supported by the strength of its operating model and increased visibility into the year ahead, including anticipated drug pricing changes. The C.

businesswire.com

Guardian Pharmacy Services, Inc. to Participate in Upcoming J.P. Morgan Healthcare Conference

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today confirmed the company will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. The company's leadership team will host investor meetings on Wednesday, January 14th, and present at 4:30 p.m. PT the same day. A live audio webcast of the session will be available at https://investors.guardianpharmacy.com. A replay will be accessible shortly after the event and will remain available for.

marketbeat.com

Guardian Pharmacy Stock Pops on Q3 Strength and Upbeat Forecast

Guardian Pharmacy Services Inc. NYSE: GRDN, a small-cap healthcare company, made waves in Tuesday's session after reporting better-than-expected earnings that sent the stock surging on above-average volume.

fool.com

Why Guardian Pharmacy Services Stock Was on a Tear Tuesday

Barely one year after its IPO, the company is doing a decent job finding its niche. This was strongly evidenced by its 20% revenue jump in the third quarter.

zacks.com

Guardian Pharmacy Services (GRDN) Q3 Earnings and Revenues Surpass Estimates

Guardian Pharmacy Services (GRDN) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to a loss of $2 per share a year ago.

seekingalpha.com

Guardian Pharmacy Services, Inc. (GRDN) Q3 2025 Earnings Call Transcript

Guardian Pharmacy Services, Inc. ( GRDN ) Q3 2025 Earnings Call November 10, 2025 4:30 PM EST Company Participants Ashley Stockton - Head of Investor Relations & Senior Director Fred Burke - CEO, President & Director David Morris - CFO, Executive VP & Director Conference Call Participants John Ransom - Raymond James & Associates, Inc., Research Division David MacDonald - Truist Securities, Inc., Research Division Raj Kumar - Stephens Inc., Research Division Presentation Operator Good day, everyone, and welcome to Guardian Pharmacy's Third Quarter Earnings Call. [Operator Instructions] I will now hand the call over to Ashley Stockton.

businesswire.com

Guardian Pharmacy Services Reports Third Quarter 2025 Financial Results; Raises Full-Year Guidance

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the third quarter ended September 30, 2025. The Company also raised its full-year revenue and Adjusted EBITDA guidance. Third Quarter Financial Results Revenue of $377.4 million, up 20% year-over-year. Residents served ended the quarter at approximately 204,000, up 13% year-over-year. Net Income (loss).

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance